Before I attempt to cover this rapidly evolving topic, I want to acknowledge a few important points: I live in a smaller body
Heres what you wont find built into MEDVis plans: MEDVi is a strong option for those who want affordable GLP-1 access and fast approvals without complicated programs
In SELECT, a trial of more than 17,000 people on semaglutide, serious adverse events were actually lower than on placebo, about 33 percent versus 36 percent (Lincoff et al., 2023)
Since HNMT (the intracellular histamine-degrading enzyme) requires SAMe, impaired methylation can slow histamine clearance, especially in tissues like the brain and airways, where HNMT is the primary clearance pathway
Similarly, a case series of four patients treated with exenatide reported improved glucose control and HbA1c after four months of therapy (40)
doi: 10.1210/er.2002-0015 156 LamosEMMalekRDavisSN